Tumors in Older Dogs: Warning Signs and Where the Research Stands
Rapavie Veterinary Team · 27 juillet 2026
Short answer: roughly half of dogs over ten will face cancer, and it is the leading cause of death in adult dogs. Most tumours are far more treatable when caught early, so the signs below are worth acting on quickly. Rapamycin — a molecule you may have read about — is being studied for canine aging, not as a tumour treatment; a lump or a changing mass needs a veterinarian, not a supplement.
7 warning signs worth a vet visit
- A lump that grows, changes, or sits under the skin and does not go away.
- A sore or wound that will not heal.
- Unexplained weight loss without a change in diet.
- Loss of appetite, or trouble eating or swallowing.
- Low energy or reluctance to exercise that is new for your dog.
- Bleeding or discharge from the mouth, nose or elsewhere.
- Lameness or stiffness that does not resolve — sometimes the first sign of bone cancer.
None of these means cancer on its own. But in an older dog, any of them earns a check-up. Early detection is the single biggest lever an owner has.
The tumours seen most often in older dogs
Some of the most common include lymphoma, mast cell tumours, hemangiosarcoma, osteosarcoma (bone), and various carcinomas of the skin and internal organs. They behave very differently — some are curable with surgery alone, others need chemotherapy or radiation. That is exactly why staging by a veterinarian matters before anything else.
Where longevity research fits (and where it doesn’t)
It is reasonable to ask whether anything lowers the long-term risk rather than only treating tumours once they appear. This is where mTOR research lives. In laboratory mammals, rapamycin reliably extends healthy lifespan; in dogs, the NIH-funded TRIAD trial is studying healthy aging with low, once-weekly dosing.
But be careful with the leap from "longevity research" to "cancer prevention". When rapamycin was tested directly against an aggressive canine cancer, it did not improve survival. So the honest framing is: rapamycin is studied for healthy aging in healthy dogs — it is not a tumour treatment and not a proven cancer preventive.
For the underlying research on canine aging, our guide to cancer in dogs goes deeper into risk and detection.
Rapamycin is not a cancer treatment. If your dog has been diagnosed with cancer, a veterinary oncologist is the right first call. If you have a healthy older dog and want to understand veterinarian-directed longevity care, talk to the Rapavie team on WhatsApp — we will tell you honestly whether it makes sense for your dog.
Questions fréquentes
What are the first signs of a tumour in an older dog?
Common early signs include a new or growing lump, a sore that will not heal, unexplained weight loss, appetite loss, new low energy, unusual bleeding, and lameness that does not resolve. Any of these in an older dog is worth a veterinary check-up.
How common is cancer in older dogs?
It is the leading cause of death in adult dogs, and roughly half of dogs over ten will face it. Early detection greatly improves the options, which is why acting quickly on warning signs matters.
Can rapamycin prevent tumours in dogs?
There is no evidence that it prevents tumours. Rapamycin is studied for healthy aging in dogs, and when tested directly against an aggressive canine cancer it did not improve survival. It should not be used as a cancer preventive.
Should I see a vet or try a supplement first?
See a veterinarian first. A lump or a changing mass needs professional assessment and staging — no supplement or longevity compound substitutes for that, and delay can narrow the treatment options.
Lire à ce sujet est la première étape. Savoir où en est votre chien est la seconde.
Chaque programme Rapavie commence par l’examen des antécédents de votre animal par un vétérinaire diplômé — pas par un produit.
La rapamycine est un médicament sur ordonnance. Rien n’est délivré sans examen vétérinaire.